A bottle of prescription opioid pills spilling onto a table.

Dangers of Opioids & Sleep Apnea 

Dangers of Opioids & Sleep Apnea 

Discovering the Dangers of Opioids and Sleep Apnea

Read the first part of our two-part series uncovering the link between opioids and sleep disorders.

The current opioid crisis is well documented. And the battle being waged to decrease the number of people addicted to, misusing, and overdosing from opioid medications is massive. Law enforcement, healthcare providers, the FDA, and CDC, addiction and pain management specialists are working together to raise awareness and curb the problem.

To help decrease the availability of and unnecessary exposure to the powerful pain pills, many doctors are recommending other solutions for pain relief. Opioid prescriptions from physicians have decreased more than 50% since 2012, according to recent studies. For the first time in nearly two decades, alternative treatments, drug-free solutions, and natural therapies are finally on the rise. This trend is partially fueled by new information that is coming out about the risks associated with opioid use.

Recent research is showing an alarming connection between long-term opioid use and an increased risk of respiratory depression during sleep. There is a high prevalence and increased incidence of sleep apnea among patients on chronic opioid therapy, with studies reporting that more than half of this population may be affected. Along with dangerous side effects, including disrupted sleep and insomnia, opioids are also putting people at higher risk for respiratory depression and sleep-related breathing disorders, namely central sleep apnea and obstructive sleep apnea. Adverse outcomes such as respiratory depression, sleep-related hypoxaemia, and even fatal overdose are important considerations in opioid therapy. So, what does this mean for patients?

Opioids & Sleep Disordered Breathing

These powerful painkillers and sleep do not mix well. All types of drugs in this category – like morphine, oxycodone, codeine sulfate, fentanyl, and hydrocodone – tend to decrease both REM and slow-wave sleep. Now, scientists are discovering that they can also cause irregular breathing during sleep. Opioids can also affect non-rapid eye movement sleep, which may further compromise ventilatory responses and increase the risk of sleep-disordered breathing.

The numbers show that a staggering 75-85%** of those taking opioids regularly have at least mild sleep apnea**, and about 40% have severe sleep apnea. This refers to complex sleep apnea, which presents symptoms and characteristics of both central and obstructive sleep apnea.

Infographic showing sleep apnea prevalence among patients on chronic opioid therapy

These drugs act on opioid receptors in the brain, which can suppress respiratory drive and increase the risk of sleep-disordered breathing. Plus, taking opioids often results in drowsiness and muscle relaxation; the use of muscle relaxants can further exacerbate sleep-related breathing problems generally associated with OSA.

Clinical data support the link between opioid use and sleep-disordered breathing, providing objective evidence for these effects. The STOP-Bang questionnaire is a useful screening tool to identify opioid patients at risk for sleep apnea, and prior diagnosis of sleep apnea is often considered as an exclusion criterion in related studies.

Studies have found that patients taking opioids as prescribed for pain are at higher risk for adverse respiratory effects and irregular central apneas in certain stages of the sleep cycle. They have also noted a correlation between higher daily doses of the pain medication and an increased frequency of central apneas. In other words, patients taking more opioids tend to have more severe sleep apnea.

What’s at Stake?

Sleep apnea, as a side effect of long-term opioid use, is serious and potentially fatal. We think two local pulmonologists in Ohio summed up this very scary risk best in their recently published article:

“Many individuals on opioids are found dead in bed, without any apparent cause. It is suspected that a terminal apnea could be a potential cause of death. It is our hope that by limiting the use of opioids, sleep-disordered breathing can be eliminated and death may be prevented in these young individuals.” – Journal of Clinical Sleep Medicine

Treatment Options for Opioid-Induced Sleep Apnea

Doctors and clinicians are currently working to understand what the best treatment options are for opioid-associated sleep apnea, between CPAP therapy and other options. The primary goal of therapy is to relieve pain while minimizing the risk of sleep-disordered breathing. Some studies have shown opioid-induced sleep apnea to be particularly resistant to CPAP therapy. Also, because CPAP therapy does not always effectively treat central sleep apnea, other treatments, such as adaptive servo-ventilation (ASV), may be recommended. When evaluating these treatment options, it is important to consider outcome measures to assess the effectiveness of interventions for opioid-induced sleep apnea.

The Search for Solutions in the Opioid Crisis

The research that has been done up to this point has revealed some important information. However, there is still a lot of work to be done. In the fight against opioids, we underline the need to make progress in three main areas. Collecting robust clinical data from multiple sites is essential to better understand the relationship between opioid use and sleep apnea. Additionally, future research should prioritize the development and use of standardized outcome measures to ensure comparability and relevance of findings.

Better Treatment Options for Chronic Pain

Sleep problems are common for those managing long-term pain or dealing with conditions such as fibromyalgia and cancer. In fact, pain is often a trigger for insomnia; about two-thirds of people with chronic pain also have a sleep disorder.

Diagram illustrating the connection between chronic pain, opioid use, and sleep apnea

In addition to the dangerous effects that sleep apnea has on the heart, brain, and general health of patients if untreated, there is also some reason to believe that disrupted sleep makes pain worse. This would indicate a negative cyclical effect between pain symptoms, medication, poor sleep, and increased pain. Chronic opioid use, often prescribed for chronic pain, increases the risk of sleep-disordered breathing such as sleep apnea, further complicating sleep and pain management. It is easy to see how this spiral could lead to over-medicating, drug dependence, and substance abuse.

Wider Use of Testing for Sleep Disorders

The rapid increase in the use of these powerful drugs has been a major concern of sleep specialists, knowing that many patients have undiagnosed sleep disorders that could be aggravated by the drug. Medical professionals caring for patients undergoing opioid therapy must be aware of the symptoms of sleep-disordered breathing, including disrupted sleep, loud snoring, and excessive daytime sleepiness.

To prevent the damaging effects of obstructive sleep apnea, it is necessary to screen people for sleep disorders before beginning a regimen of prescription opioids. Screening protocols should also consider any prior diagnosis of sleep apnea or other sleep disorders to ensure patient safety. The STOP-Bang questionnaire is a validated tool commonly used to identify patients at risk for sleep-disordered breathing, including those with a higher likelihood of moderate-to-severe sleep apnea. 

Going forward, sleep clinicians and doctors should work together to ensure that any disordered breathing that develops is quickly and effectively treated. Regular screening can determine when CPAP therapy or other treatment options should be introduced to keep the patient healthy.

Caution When Prescribing Medication

Healthcare providers at every level are actively working to decrease the number of prescriptions given for opioid medication and the dosage amounts recommended. The American Academy of Sleep Medicine has advocated against giving opioids for long-term pain due to the potentially dangerous effects of respiratory depression. It is important to monitor for adverse events, such as sleep apnea, sleep-related hypoxaemia, and fatal overdose, especially in high-risk groups. Ultra-rapid metabolizers, who convert codeine to morphine more quickly, are at increased risk of adverse events and require special consideration. As healthcare professionals, we should favor drug-free therapies whenever appropriate and continue to use caution when prescribing medications.

Get more information about effective, drug-free treatment options for Insomnia, alternative treatments for Obstructive Sleep Apnea, and Central Sleep Apnea

Reliable Sleep Testing Services

Quality sleep is an important part of your overall health and a proper diagnosis is crucial to safe medical care. The clinical site at Sleep Health Solutions in Cuyahoga Falls, Ohio, provides comprehensive sleep testing and data collection, offering a full range of clinical and at-home sleep testing. Contact us today to schedule a consultation.



Author Picture

Our Location

Sleep Health Solutions
267 Portage Trail Extension
West Suite 100,
Cuyahoga Falls, OH 44223
Phone: (330) 923-0228
Fax: (330) 923-1020

Hours

Monday through Friday: 9:00 AM – 5:00 PM
Saturday and Sunday: By appointment only

Directions

Connect With Us

Contact Us

Please fill out the fields below and one of our specialists will contact you shortly. Want to speak to us now? Call us at (330) 923-0228.

Contact Us
Sending

Sleep Health Solutions is serious about privacy. We will never share your information with third parties. Please read our Privacy Policy for more information.

Sleep Health Solutions